Concepedia

Saul A. Schepartz

SA

Statistics

Publications

11

Citations

2.1K

H-Index

11

Active since

1955

Affiliations

National Cancer Institute(Current)

National Cancer Institute

University of Wisconsin–Madison

Saul A. Schepartz is an author at National Cancer Institute specializing in pharmacology, drug discovery, and medicine.

Publications per year

1955–2001

11

Publications

11

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

J I Johnson, Shannon Decker, Daniel Zaharevitz et al. · British Journal of Cancer · 2001 · 858 citations · Full text

, , +14

The National Cancer Institute: cancer drug discovery and development program.

Michael R. Grever, Saul A. Schepartz, B A Chabner · PubMed · 1992 · 721 citations

, , +11

The Taxol Supply Crisis. New NCI Policies for Handling the Large-Scale Production of Novel Natural Product Anticancer and Anti-HIV Agents

Gordon M. Cragg, Saul A. Schepartz, Matthew Suffness et al. · Journal of Natural Products · 1993 · 308 citations

, , +8

THE NATURE OF THE BINDING OF PENICILLIN BY BACTERIAL CELLS

Saul A. Schepartz, Marvin J. Johnson · Journal of Bacteriology · 1956 · 43 citations · Full text

, , +8

Summary of the Workshop on Drug Development, Biological Diversity, and Economic Growth

Jochen Schweitzer, F. G. Handley, John D. Edwards et al. · JNCI Journal of the National Cancer Institute · 1991 · 32 citations

, , +15

1–5 of 11